Who
Eran Ophir
President and CEO
Company insider
Files Form 4 as: President and CEO, Compugen.
In numbers
- Trades disclosed
- 20
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $86K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Apr 2026
- Last trade
- 29 Jul 2026
- Last filed
- 30 Jul 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jul 2026filed 30 Jul 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 29 Jul 2026filed 30 Jul 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 24 Apr 2026filed 27 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code M | $4,1465,000 at $0.8292 | filing |
| 24 Apr 2026filed 27 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Sold | $16K5,000 at $3.20 | filing |
| 24 Apr 2026filed 27 Apr 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 24 Apr 2026filed 27 Apr 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 24 Apr 2026filed 27 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code M | $4,1505,000 at $0.83 | filing |
| 24 Apr 2026filed 27 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Sold | $16K5,000 at $3.20 | filing |
| 14 Apr 2026filed 15 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code M | $4,1465,000 at $0.8292 | filing |
| 14 Apr 2026filed 15 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Sold | $15K5,000 at $2.90 | filing |
| 14 Apr 2026filed 15 Apr 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 14 Apr 2026filed 15 Apr 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 14 Apr 2026filed 15 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code M | $4,1505,000 at $0.83 | filing |
| 14 Apr 2026filed 15 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Sold | $15K5,000 at $2.90 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code M | $4,6645,625 at $0.8292 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Sold | $12K5,625 at $2.21 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,625 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,625 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code M | $4,6695,625 at $0.83 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Sold | $12K5,625 at $2.21 | filing |
News
No headline names them, or the companies they trade most, lately.